Partners 2022



Expertise Partner

AmplifyBio partners with clients for preclinical safety, efficacy, toxicology studies now offering genetic and immune modified large and small animal models, expanded dose routes, and surgical techniques to meet the needs of advanced therapy clients. AmplifyBio has also invested heavily in capabilities for molecular and immunological assessments that complement in vivo work. The new labs include dPCR platforms, spectral cytometry, in-vivo imaging, and improved immunological assay multiplexing ability to give a complete system picture of the drug’s function and characteristics at the preclinical stage.